We are live on
!
Find out more
EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
This Fund
S&P 500
This Quarter
Est. Return
-8.89%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$602M
AUM Growth
-$131M
(-18%)
Cap. Flow
-$51M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
19.62%
Holding
196
New
22
Increased
46
Reduced
108
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$6.99M |
| 2 |
Semtech
SMTC
|
+$4.05M |
| 3 |
Marvell Technology
MRVL
|
+$3.94M |
| 4 |
Protagonist Therapeutics
PTGX
|
+$2.98M |
| 5 |
Birkenstock
BIRK
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$7.41M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.2M |
| 3 |
Shift4
FOUR
|
+$3.98M |
| 4 |
Roivant Sciences
ROIV
|
+$3.82M |
| 5 |
Alkermes
ALKS
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.07% |
| 2 | Healthcare | 26.2% |
| 3 | Industrials | 12.62% |
| 4 | Consumer Discretionary | 12.17% |
| 5 | Financials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NVIDIA
NVDA
$5.06T
| $16.1M | 2.67% |
147,627
-28,697
| -16% | -$3.64M |
|
2
Amazon
AMZN
$2.51T
| $16M | 2.66% |
84,126
-9,536
| -10% | -$2.07M |
|
3
Alphabet (Google) Class A
GOOGL
$3.88T
| $14.9M | 2.47% |
96,319
-3,474
| -3% | -$630K |
|
4
Meta Platforms (Facebook)
META
$1.54T
| $13.6M | 2.25% |
23,533
-906
| -4% | -$585K |
|
|
5
Apple
AAPL
$4.72T
| $12.6M | 2.1% |
56,780
-31,994
| -36% | -$7.41M |
|
6
Palantir
PLTR
$296B
| $11.6M | 1.92% |
137,237
-35,445
| -21% | -$3.11M |
|
|
7
Eli Lilly
LLY
$1.06T
| $9.71M | 1.61% |
11,761
+8,397
| +250% | +$6.99M |
|
8
Broadcom
AVGO
$1.87T
| $8.32M | 1.38% |
49,672
-3,761
| -7% | -$796K |
|
9
Netflix
NFLX
$287B
| $8M | 1.33% |
85,780
-4,800
| -5% | -$456K |
|
10
Intuitive Surgical
ISRG
$119B
| $7.31M | 1.21% |
14,759
-3,895
| -21% | -$2.15M |
|
11
Insmed
INSM
$23.3B
| $7.18M | 1.19% |
94,225
-13,400
| -12% | -$1.03M |
|
12
Veeva Systems
VEEV
$29.2B
| $6.68M | 1.11% |
28,842
-5,734
| -17% | -$1.31M |
|
13
Alnylam Pharmaceuticals
ALNY
$35.9B
| $6.67M | 1.11% |
24,691
-1,955
| -7% | -$502K |
|
14
Halozyme
HALO
$9.59B
| $6.57M | 1.09% |
103,092
-25,202
| -20% | -$1.46M |
|
15
Visa
V
$669B
| $6.57M | 1.09% |
18,760
-4,603
| -20% | -$1.56M |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $6.5M | 1.08% |
73,388
-912
| -1% | -$89K |
|
17
argenx
ARGX
$57.8B
| $6.37M | 1.06% |
10,755
-3,769
| -26% | -$2.38M |
|
18
Veracyte
VCYT
$4.62B
| $5.92M | 0.98% |
199,653
-6,574
| -3% | -$251K |
|
19
Costco
COST
$411B
| $5.8M | 0.96% |
6,133
-966
| -14% | -$942K |
|
|
AXON
20
Axon Enterprise
AXON
$39.6B
| $5.67M | 0.94% |
10,783
+2,206
| +26% | +$1.29M |
|
21
Home Depot
HD
$324B
| $5.34M | 0.89% |
14,577
+1,134
| +8% | +$442K |
|
22
Commault Systems
CVLT
$5.85B
| $5.26M | 0.87% |
33,294
-128
| -0.4% | -$21.1K |
|
23
Glaukos
GKOS
$8.94B
| $5.22M | 0.87% |
53,076
-7,516
| -12% | -$1M |
|
24
Vertiv
VRT
$117B
| $5.17M | 0.86% |
71,562
+23,365
| +48% | +$2.49M |
|
25
Idexx Laboratories
IDXX
$42.5B
| $5.1M | 0.85% |
12,153
-1,222
| -9% | -$531K |
|
Similar funds
HWM
CP
BVDMP
MSAM
WA
PAS
NSEDCP
RAM
EFG Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, EFG Asset Management held 196 positions worth $602M, down 18% from $732M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
EFG Asset Management withdrew a net $51M in Q1 2025, closing 20 positions and reducing 108 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EFG Asset Management opened a new position in Semtech worth $2.82M.
- EFG Asset Management's largest Q1 2025 buy was Semtech: 82,076 shares worth $2.82M.
- EFG Asset Management added most to Eli Lilly in Q1 2025, an estimated $6.99M increase.
- EFG Asset Management's biggest Q1 2025 reduction was Apple, cutting an estimated $7.41M.
- EFG Asset Management fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $6.2M.
- EFG Asset Management's ten largest holdings make up 20% of its $602M portfolio in Q1 2025.
- EFG Asset Management opened 22 new positions and closed 20 in Q1 2025.
- EFG Asset Management's portfolio value fell 18% quarter-over-quarter to $602M.
Based on EFG Asset Management's 13F filing for Q1 2025, filed 15 May 2025.